SecBot SecBot
S-3/A ·Filed Nov 5, 2026

PMI

Picard Medical, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed11d 9h ago SEC0001437749-26-035285
Shelf registration amendment
Actionable Insight ▼ Bearish

Monitor for selling by the three noteholder selling stockholders, who collectively could sell up to 500,000 shares. The stock's high volatility (11.8% normal daily move) and low market cap ($19M) mean even partial selling could pressure the price. The company's need for further capital (given NYSE non-compliance and going concern) may lead to additional dilutive financing.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$9.00
T+0 close · Nov 5, 2026 · via day close
Latest settled
−19.67%
T+5 · $7.23 · next T+20 in 20d
Vs SPY
−22.26%
α at T+5
Latest observation
−15.41%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $9.00entry
  2. T+1 · 8d ago −6.22%α −8.59% · $8.44
  3. T+5 · 4d ago −19.67%α −22.26% · $7.23
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Picard Medical filed Amendment No. 1 to its S-3 registration statement to register up to 500,000 shares of common stock for resale by selling stockholders. These shares are issuable upon conversion of $1.0 million in convertible notes issued on September 30, 2026, and upon exercise of related pre-funded warrants. The company will not receive any proceeds from the resale, but the registration enables potential near-term selling by noteholders, adding overhang to a stock with a $19M market cap and 2.46M shares outstanding.

Key Financial Metrics

Offering Size
$1.0M
Dilution
20.3%

Key Facts

  • Registers up to 500,000 shares for resale by three selling stockholders (Fengjun Xue, Xiangdie Liu, Xiangyang Xu).
  • Shares consist of up to 250,000 shares issuable upon conversion of $1.0M convertible notes (3% interest, floor price $4.00) and up to 250,000 shares issuable upon exercise of pre-funded warrants at $0.0001 per share.
  • Convertible notes were issued on September 30, 2026; warrants are exercisable 60 days after issuance and expire in two years.
  • Company will not receive any proceeds from the resale.
  • As of October 13, 2026, there were 2,458,574 shares outstanding; full conversion and exercise would increase that to 2,958,574 shares (20.3% dilution).
  • Market cap is $19M; the $1.0M note principal represents ~5.3% of market cap.
  • Company is non-compliant with NYSE American stockholders' equity rule (reported $3.8M equity as of Dec 31, 2025) and has an accepted compliance plan with a deadline of November 8, 2027.
  • Company has a history of frequent capital raises: 19 offering/registration filings in the last 24 months.
  • Auditor's report on 2025 financials includes a going concern explanatory paragraph.

Financial Impact

Potential dilution of 20.3% (500,000 new shares vs 2,458,574 outstanding). The $1.0M convertible note principal is 5.3% of the $19M market cap.

dilutionshare count

Risk Factors

  • Potential overhang from resale of up to 500,000 shares (20.3% of current outstanding).
  • Company is not receiving any proceeds from this registration, so it does not address its capital needs.
  • NYSE American non-compliance for stockholders' equity remains unresolved; failure to regain compliance by November 8, 2027 could lead to delisting.
  • Auditor's going concern qualification indicates risk of insufficient capital.
  • Frequent past equity raises (19 filings in 24 months) suggest ongoing cash burn.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
S-3/A Filing (Primary)0001437749-26-035285
Document: 0001437749-26-035285-index-headers.html0001437749-26-035285
Document: 0001437749-26-035285-index.html0001437749-26-035285
Document: 0001437749-26-035285.txt0001437749-26-035285

Track record

27 reports on PMI

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +138.72% at T+60 after the Jul 27, 2026 report. 11 of 13 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 6/10 Entry $7.24 Now $7.24 +0.00% settles Feb 16
  2. Nov 12, 20265d ago EFFECT Bearish 5/10 Entry $7.85 Now $7.24 +7.77% settles Feb 10
  3. Nov 5, 202611d ago S-3/A Bearish 5/10 Viewing Entry $9.00 Now $7.24 +19.56% settles Feb 4
  4. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $7.19 Now $7.24 −0.70% settles Feb 2
  5. Oct 23, 202624d ago 8-K Mixed 5/10 Entry $6.43 Now $7.24 +12.60% settles Jan 22
  6. Oct 22, 202625d ago S-3 Bearish 6/10 Entry $7.37 Now $7.24 +1.76% settles Jan 20
  7. Oct 6, 20265w ago 8-K Bearish 6/10 Entry $8.74 Now $7.24 +17.16% settles Dec 31
  8. Jul 27, 202616w ago 8-K Bullish 6/10 Entry $0.0878 to $0.2096 Now $7.24 +8146.01% ▲ +138.72% +134.67% vs SPY
  9. Jul 15, 202617w ago DEFA14A Neutral 2/10 Entry $0.1600 to $0.1896 Now $7.24 +4425.00% ▲ +18.50% +14.79% vs SPY
  10. Jul 8, 202618w ago DEFA14A Neutral 2/10 Entry $0.1500 to $0.0864 Now $7.24 +4726.67% ▼ −42.40% −44.89% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens in 7h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026